JP2009544758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544758A5 JP2009544758A5 JP2009522956A JP2009522956A JP2009544758A5 JP 2009544758 A5 JP2009544758 A5 JP 2009544758A5 JP 2009522956 A JP2009522956 A JP 2009522956A JP 2009522956 A JP2009522956 A JP 2009522956A JP 2009544758 A5 JP2009544758 A5 JP 2009544758A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- disease
- salt
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CCOC([C@](CC(CC1)N(C)C(C)C)C1N(CC[C@@]1*)C1=O)=O Chemical compound CCOC([C@](CC(CC1)N(C)C(C)C)C1N(CC[C@@]1*)C1=O)=O 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83423506P | 2006-07-28 | 2006-07-28 | |
| US89602607P | 2007-03-21 | 2007-03-21 | |
| US11/782,704 US7671062B2 (en) | 2006-07-28 | 2007-07-25 | Modulators of chemokine receptor activity, crystalline forms and process |
| PCT/US2007/074438 WO2008014381A2 (en) | 2006-07-28 | 2007-07-26 | Modulators of chemokine receptor activity, crystalline forms and process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009544758A JP2009544758A (ja) | 2009-12-17 |
| JP2009544758A5 true JP2009544758A5 (https=) | 2010-08-12 |
Family
ID=38823540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009522956A Withdrawn JP2009544758A (ja) | 2006-07-28 | 2007-07-26 | ケモカイン受容体活性のモジュレーター、結晶形および方法 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7671062B2 (https=) |
| EP (2) | EP2184283A1 (https=) |
| JP (1) | JP2009544758A (https=) |
| KR (1) | KR20090035036A (https=) |
| CN (1) | CN101511822A (https=) |
| AR (1) | AR062114A1 (https=) |
| AT (1) | ATE471928T1 (https=) |
| AU (1) | AU2007279256A1 (https=) |
| BR (1) | BRPI0715066A2 (https=) |
| CA (1) | CA2659259A1 (https=) |
| CL (3) | CL2007002196A1 (https=) |
| CO (1) | CO6190527A2 (https=) |
| CY (1) | CY1110785T1 (https=) |
| DE (1) | DE602007007335D1 (https=) |
| DK (1) | DK2049477T3 (https=) |
| EA (1) | EA014960B1 (https=) |
| ES (1) | ES2346591T3 (https=) |
| HR (1) | HRP20100371T1 (https=) |
| IL (1) | IL196518A0 (https=) |
| MX (1) | MX2009000803A (https=) |
| NO (1) | NO20090256L (https=) |
| NZ (1) | NZ574656A (https=) |
| PE (1) | PE20080838A1 (https=) |
| PL (1) | PL2049477T3 (https=) |
| PT (1) | PT2049477E (https=) |
| SG (1) | SG158925A1 (https=) |
| SI (1) | SI2049477T1 (https=) |
| TW (1) | TW200823203A (https=) |
| WO (1) | WO2008014381A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7687508B2 (en) * | 2006-07-28 | 2010-03-30 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| US8383812B2 (en) | 2009-10-13 | 2013-02-26 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| ES2904252T3 (es) * | 2015-05-21 | 2022-04-04 | Chemocentryx Inc | Moduladores de CCR2 |
| SMT202200088T1 (it) * | 2017-07-20 | 2022-03-21 | Bristol Myers Squibb Co | Procedimento per la preparazione di n-((1r,2s,sr)-5-(tert-butilammino)-2-((s)-3-(7-tert-butilpirazolo[1,5-a][1,3,5]triazin-4-ilammino)-2-ossopirrolidin-1-il)cicloesil)acetammide |
| CN118267479A (zh) | 2017-09-25 | 2024-07-02 | 凯莫森特里克斯股份有限公司 | 使用趋化因子受体2(ccr2)拮抗剂和pd-1/pd-l1抑制剂的联合治疗 |
| US20190269664A1 (en) | 2018-01-08 | 2019-09-05 | Chemocentryx, Inc. | Methods of treating solid tumors with ccr2 antagonists |
| IL275898B2 (en) | 2018-01-08 | 2025-05-01 | Chemocentryx Inc | Methods for treating solid tumors with CCR2 antagonists |
| CN115494184B (zh) * | 2022-05-09 | 2023-07-28 | 浙江海正药业股份有限公司 | 一种同时检测药物中异丙苯磺酸甲酯、异丙苯磺酸乙酯的方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6383082A (ja) | 1986-09-26 | 1988-04-13 | Takeda Chem Ind Ltd | テトラヒドロフランカルボン酸誘導体の製造法 |
| CA2084800A1 (en) | 1991-12-16 | 1993-06-17 | Joseph P. Vacca | Hiv protease inhibitors with an internal lactam ring |
| GB9515411D0 (en) | 1995-07-27 | 1995-09-27 | Pharmacia Spa | N-(4-substituted-benzyl)-2-aminolactam derivatives |
| US5827875A (en) | 1996-05-10 | 1998-10-27 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| UA51716C2 (uk) | 1996-07-08 | 2002-12-16 | Авентіс Фармасьютікалз Продактс Інк. | Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування |
| US6054579A (en) | 1997-06-26 | 2000-04-25 | Leukosite, Inc. | Synthesis of substituted lactams |
| GB9716656D0 (en) | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
| TR200002182T2 (tr) | 1998-01-27 | 2000-12-21 | Aventis Pharmaceuticals Products Inc. | İkame edilmiş aksozaherosayklil faktör xa inhibitörleri |
| US6492553B1 (en) | 1998-01-29 | 2002-12-10 | Aventis Pharamaceuticals Inc. | Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compounds |
| PL342254A1 (en) | 1998-01-29 | 2001-06-04 | Aventis Pharm Prod Inc | Method of obtaining n-[(aliphatic or aromatic substituend)carbonyl)]-2-aminacetamide and cyclised compound |
| GB9803228D0 (en) | 1998-02-17 | 1998-04-08 | Zeneca Ltd | Chemical compounds |
| US6541208B1 (en) | 1998-03-17 | 2003-04-01 | University Of Maryland Biotechnology Institute | Diagnostic method for distinguishing HIV-associated dementia from other forms of dementia |
| WO2001017992A1 (en) | 1999-09-09 | 2001-03-15 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| US6620823B2 (en) | 2000-07-11 | 2003-09-16 | Bristol-Myers Squibb Pharme Company | Lactam metalloprotease inhibitors |
| WO2002060859A2 (en) | 2000-12-20 | 2002-08-08 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| CA2432908A1 (en) * | 2000-12-20 | 2002-06-27 | Bristol-Myers Squibb Pharma Company | Diamines as modulators of chemokine receptor activity |
| AU2002249103A1 (en) | 2001-03-29 | 2002-10-15 | Topo Target Aps | Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors |
| GB0114867D0 (en) | 2001-06-18 | 2001-08-08 | Merck Sharp & Dohme | Therapeutic agents |
| DE10135043A1 (de) | 2001-07-11 | 2003-01-30 | Bayer Cropscience Gmbh | Substituierte 3-Heteroaryl(amino- oder oxy)-pyrrolidin-2-one, Verfahren zu deren Herstellung und Verwendung als Herbizide oder als Pflanzenwachstumsregulatoren |
| US7087604B2 (en) * | 2002-03-08 | 2006-08-08 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| TW200307667A (en) * | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| WO2004022536A1 (en) | 2002-09-04 | 2004-03-18 | Glenmark Pharmaceuticals Limited | New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| TW200508224A (en) | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
| WO2004071449A2 (en) * | 2003-02-12 | 2004-08-26 | Bristol-Myers Squibb Company | Lactams as modulators of chemokine receptor activity |
| US7230133B2 (en) * | 2003-05-01 | 2007-06-12 | Bristol-Myers Squibb Company | Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| US7291615B2 (en) | 2003-05-01 | 2007-11-06 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| US20060205761A1 (en) | 2003-06-06 | 2006-09-14 | Catherine Abbadie | Ccr-2 antagonists for treatment of neuropathic pain |
| US7317019B2 (en) * | 2003-08-21 | 2008-01-08 | Bristol Myers Squibb Co. | N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| US20050043392A1 (en) * | 2003-08-21 | 2005-02-24 | Carter Percy H. | Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| US7863317B2 (en) * | 2003-08-21 | 2011-01-04 | Bristol-Myers Squibb Company | Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| US7378409B2 (en) * | 2003-08-21 | 2008-05-27 | Bristol-Myers Squibb Company | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| CA2575612A1 (en) | 2004-07-30 | 2006-02-09 | Pfizer Products Inc. | Methods of treating ccr2 mediated diseases or disorders |
| US20060069123A1 (en) * | 2004-09-28 | 2006-03-30 | Mingde Xia | Substituted dipiperidine CCR2 antagonists |
-
2007
- 2007-07-25 US US11/782,704 patent/US7671062B2/en active Active
- 2007-07-26 DE DE602007007335T patent/DE602007007335D1/de active Active
- 2007-07-26 ES ES07799831T patent/ES2346591T3/es active Active
- 2007-07-26 CL CL200702196A patent/CL2007002196A1/es unknown
- 2007-07-26 CA CA002659259A patent/CA2659259A1/en not_active Abandoned
- 2007-07-26 CN CNA2007800327628A patent/CN101511822A/zh active Pending
- 2007-07-26 BR BRPI0715066-0A patent/BRPI0715066A2/pt not_active IP Right Cessation
- 2007-07-26 NZ NZ574656A patent/NZ574656A/en not_active IP Right Cessation
- 2007-07-26 SI SI200730305T patent/SI2049477T1/sl unknown
- 2007-07-26 MX MX2009000803A patent/MX2009000803A/es active IP Right Grant
- 2007-07-26 PL PL07799831T patent/PL2049477T3/pl unknown
- 2007-07-26 TW TW096127306A patent/TW200823203A/zh unknown
- 2007-07-26 CL CL200702194A patent/CL2007002194A1/es unknown
- 2007-07-26 PT PT07799831T patent/PT2049477E/pt unknown
- 2007-07-26 CL CL200702195A patent/CL2007002195A1/es unknown
- 2007-07-26 JP JP2009522956A patent/JP2009544758A/ja not_active Withdrawn
- 2007-07-26 PE PE2007000968A patent/PE20080838A1/es not_active Application Discontinuation
- 2007-07-26 EP EP10001344A patent/EP2184283A1/en not_active Withdrawn
- 2007-07-26 AR ARP070103321A patent/AR062114A1/es not_active Application Discontinuation
- 2007-07-26 WO PCT/US2007/074438 patent/WO2008014381A2/en not_active Ceased
- 2007-07-26 EP EP07799831A patent/EP2049477B1/en not_active Not-in-force
- 2007-07-26 AU AU2007279256A patent/AU2007279256A1/en not_active Abandoned
- 2007-07-26 AT AT07799831T patent/ATE471928T1/de active
- 2007-07-26 DK DK07799831.8T patent/DK2049477T3/da active
- 2007-07-26 KR KR1020097004327A patent/KR20090035036A/ko not_active Withdrawn
- 2007-07-26 SG SG201000704-5A patent/SG158925A1/en unknown
- 2007-07-26 EA EA200900244A patent/EA014960B1/ru not_active IP Right Cessation
- 2007-07-26 HR HR20100371T patent/HRP20100371T1/hr unknown
-
2009
- 2009-01-15 IL IL196518A patent/IL196518A0/en unknown
- 2009-01-16 NO NO20090256A patent/NO20090256L/no not_active Application Discontinuation
- 2009-01-27 CO CO09007271A patent/CO6190527A2/es not_active Application Discontinuation
-
2010
- 2010-09-22 CY CY20101100852T patent/CY1110785T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009544758A5 (https=) | ||
| JP6966590B2 (ja) | オメカムチブメカルビルの塩及び塩を調製するプロセス | |
| CA2530159C (en) | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors | |
| JP2009544756A5 (https=) | ||
| JP5273587B2 (ja) | キナゾリンジオン骨格を有するフェニルアラニン誘導体の製造方法及び製造中間体 | |
| JP6158811B2 (ja) | ４−［５−（ピリジン−４−イル）−１ｈ−１，２，４−トリアゾール−３−イル］ピリジン−２−カルボニトリルの結晶多形およびその製造方法 | |
| JP2024503855A (ja) | アミノピリミジン系ｆａｋ阻害剤化合物を合成する方法 | |
| JP2005503386A5 (https=) | ||
| JP2009508949A5 (https=) | ||
| CA2660320A1 (en) | Morpholinyl and pyrrolidinyl analogs | |
| CN104884427B (zh) | 可用于合成苯甲酰胺化合物的化合物 | |
| HRP20140072T1 (hr) | N-((1r,2s,5r)-5-(terc-butilamino)-2-((s)-3-(7-terc-butilpirazolo[1,5-a][1,3,5]triazin-4-ilamino)-2-oksopirolidin-1-il)cikliheksil)acetamid, dvostruki modulator aktivnosti receptora za hemokin, kristalni oblici i postupci | |
| EP2834224A2 (en) | Process for the preparation of benzimidazole derivatives and salts thereof | |
| AU2012229859C1 (en) | Nitrogen-containing saturated heterocyclic compound | |
| HRP20100371T1 (hr) | Modulatori aktivnosti kemokinskih receptora, kristalni oblici i postupci | |
| Zhou et al. | Design and synthesis of highly selective pyruvate dehydrogenase complex E1 inhibitors as bactericides | |
| HRP20110465T1 (hr) | Modulatori aktivnosti receptora kemokina, kristalni oblici i postupak | |
| CN107810189B (zh) | 用于制备氮芥衍生物的方法 | |
| JP2011105685A (ja) | フェネチルアミン化合物の結晶 | |
| CN106317020A (zh) | 富马酸沃诺拉赞晶型α及其制备方法 | |
| CN116947763A (zh) | 2-巯基-5-氰基-6-芳基嘧啶杂环类化合物、制备方法和应用 | |
| WO2025247412A1 (zh) | 一种苯基噻唑胺类PI4KIII β/HDAC双靶抑制剂、制备方法及其药物组合物和应用 | |
| WO2018233727A1 (zh) | 一种吲哚类化合物及其应用，一种药物组合物及其应用 | |
| KR20180044384A (ko) | Ror 감마 조절인자로서 신규의 카보사이클릭 화합물 | |
| CN103570605B (zh) | 特拉匹韦及其中间体的制备方法 |